AVTR Logo

AVTR Stock Forecast: Avantor Inc. Price Predictions for 2026

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Instruments & Supplies

$11.38

-0.32 (-2.74%)

AVTR Stock Forecast 2025-2026

$11.38
Current Price
$7.76B
Market Cap
18 Ratings
Buy 5
Hold 13
Sell 0
Wall St Analyst Ratings

Distance to AVTR Price Targets

+67.0%
To High Target of $19.00
+14.2%
To Median Target of $13.00
+5.4%
To Low Target of $12.00

AVTR Price Momentum

-1.5%
1 Week Change
-21.9%
1 Month Change
-45.1%
1 Year Change
-46.0%
Year-to-Date Change
-51.2%
From 52W High of $23.32
+5.1%
From 52W Low of $10.83
๐Ÿ“Š TOP ANALYST CALLS

Did AVTR Make This Month's Elite Buy List?

We don't follow just any analyst โ€” only the top 3% with a proven track record make our cut. See if Avantor is one of their latest high-conviction picks.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest AVTR Stock Price Targets & Analyst Predictions

Based on our analysis of 32 Wall Street analysts, AVTR has a neutral consensus with a median price target of $13.00 (ranging from $12.00 to $19.00). The overall analyst rating is Buy (7.1/10). Currently trading at $11.38, the median forecast implies a 14.2% upside. This outlook is supported by 5 Buy, 13 Hold, and 0 Sell ratings.

Conversely, the most conservative target is provided by Luke Sergott at Barclays, suggesting a 5.4% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

AVTR Analyst Ratings

5
Buy
13
Hold
0
Sell

AVTR Price Target Range

Low
$12.00
Average
$13.00
High
$19.00
Current: $11.38

Latest AVTR Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for AVTR.

Date Firm Analyst Rating Change Price Target
Oct 30, 2025 Evercore ISI Group Vijay Kumar Outperform Maintains $14.00
Oct 30, 2025 Barclays Luke Sergott Equal-Weight Downgrade $12.00
Oct 30, 2025 JP Morgan Casey Woodring Neutral Downgrade $12.00
Oct 24, 2025 Baird Catherine Schulte Outperform Maintains $17.00
Oct 16, 2025 Raymond James Andrew Cooper Outperform Maintains $16.00
Oct 2, 2025 Barclays Luke Sergott Overweight Maintains $15.00
Aug 4, 2025 Stifel Daniel Arias Hold Maintains $12.00
Aug 4, 2025 Morgan Stanley Tejas Savant Equal-Weight Maintains $12.00
Aug 4, 2025 RBC Capital Conor McNamara Outperform Maintains $17.00
Aug 4, 2025 JP Morgan Rachel Vatnsdal Overweight Maintains $14.00
Aug 4, 2025 Evercore ISI Group Vijay Kumar Outperform Maintains $16.00
Aug 4, 2025 Raymond James Andrew Cooper Outperform Reiterates $14.00
Aug 4, 2025 Barclays Luke Sergott Overweight Maintains $13.00
Aug 4, 2025 Baird Catherine Schulte Outperform Maintains $15.00
Aug 4, 2025 Wells Fargo Brandon Couillard Overweight Maintains $16.00
Jul 28, 2025 Baird Catherine Schulte Outperform Maintains $18.00
Apr 29, 2025 Goldman Sachs Matthew Sykes Neutral Downgrade $14.00
Apr 28, 2025 Barclays Luke Sergott Overweight Maintains $15.00
Apr 28, 2025 Morgan Stanley Tejas Savant Equal-Weight Downgrade $15.00
Apr 28, 2025 Baird Catherine Schulte Outperform Maintains $17.00

Avantor Inc. (AVTR) Competitors

The following stocks are similar to Avantor based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Avantor Inc. (AVTR) Financial Data

Avantor Inc. has a market capitalization of $7.76B with a P/E ratio of 14.9x. The company generates $6.58B in trailing twelve-month revenue with a -1.3% profit margin.

Revenue growth is -5.3% quarter-over-quarter, while maintaining an operating margin of +8.5% and return on equity of -1.5%.

Valuation Metrics

Market Cap $7.76B
Enterprise Value $11.37B
P/E Ratio 14.9x
PEG Ratio 0.0x
Price/Sales 1.2x

Growth & Margins

Revenue Growth (YoY) -5.3%
Gross Margin +32.4%
Operating Margin +8.5%
Net Margin -1.3%
EPS Growth -5.3%

Financial Health

Cash/Price Ratio +3.2%
Current Ratio 1.5x
Debt/Equity 69.3x
ROE -1.5%
ROA +3.4%
๐Ÿ’ก SKIP THE NOISE

97% of Analyst Ratings Go Nowhere

We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ€” tracked and updated every Monday and Thursday.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Avantor Inc. logo

Avantor Inc. (AVTR) Business Model

About Avantor Inc.

What They Do

Provider of critical products for life sciences.

Business Model

Avantor Inc. generates revenue by supplying a comprehensive range of laboratory chemicals, consumables, equipment, and instrumentation to various sectors, including life sciences, advanced technologies, and applied materials. The company serves a diverse clientele, including pharmaceutical, biotechnology, academic, and government institutions, facilitating their research, development, and manufacturing processes.

Additional Information

Operating in over 30 countries, Avantor's integrated solutions support scientific applications that enhance healthcare and public welfare. The company's focus on sustainability and compliance strengthens its market position as a trusted supplier in essential science and technology products.

Company Information

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

13,500

CEO

Mr. Emmanuel Ligner

Country

United States

IPO Year

2019

Avantor Inc. (AVTR) Latest News & Analysis

Latest News

AVTR stock latest news image
Quick Summary

A class action lawsuit has been filed against Avantor, Inc. (NYSE: AVTR) and its officers, as announced by law firm Bronstein, Gewirtz & Grossman, LLC on Nov. 13, 2025.

Why It Matters

A class action lawsuit against Avantor could lead to financial liabilities and reputational damage, potentially affecting stock performance and investor returns.

Source: GlobeNewsWire
Market Sentiment: Neutral
AVTR stock latest news image
Quick Summary

Investors in Avantor, Inc. (NYSE: AVTR) have until December 29, 2025, to file a lead plaintiff motion in a class action for shares acquired between March 5, 2024, and October 28, 2025.

Why It Matters

The deadline for filing a lead plaintiff motion in the Avantor class action could impact share value and investor recoveries, influencing market sentiment and trading strategies.

Source: GlobeNewsWire
Market Sentiment: Neutral
AVTR stock latest news image
Quick Summary

A class action lawsuit has been filed against Avantor, Inc. (NYSE: AVTR) for securities violations. Affected investors from March 5, 2024, to October 28, 2025, should contact Schall Law Firm by December 29, 2025.

Why It Matters

The class action lawsuit against Avantor could lead to financial liabilities and impact the company's stock price, affecting current and potential investors' positions.

Source: GlobeNewsWire
Market Sentiment: Neutral
AVTR stock latest news image
Quick Summary

A securities class action lawsuit has been filed against Avantor, Inc. (NYSE: AVTR) on behalf of investors who purchased shares between March 5, 2024, and October 28, 2025.

Why It Matters

A class action lawsuit against Avantor could signal potential financial liabilities, impacting stock performance and investor sentiment in the company.

Source: GlobeNewsWire
Market Sentiment: Neutral
AVTR stock latest news image
Quick Summary

Levi & Korsinsky, LLP has announced a class action securities lawsuit against Avantor, Inc. (NYSE: AVTR), notifying investors of the legal proceedings.

Why It Matters

A class action lawsuit against Avantor, Inc. could lead to financial repercussions, affecting stock value, investor confidence, and potential liabilities for the company.

Source: GlobeNewsWire
Market Sentiment: Neutral
AVTR stock latest news image
Quick Summary

Avantor, Inc. (NYSE: AVTR) investors who experienced losses may explore recovery options under federal securities laws. More information is available via the provided link.

Why It Matters

The news indicates potential legal action against Avantor, Inc., which could impact stock value and investor sentiment, signaling risks associated with the companyโ€™s financial integrity.

Source: Newsfile Corp
Market Sentiment: Neutral

Frequently Asked Questions About AVTR Stock

What is Avantor Inc.'s (AVTR) stock forecast for 2026?

Based on our analysis of 32 Wall Street analysts, Avantor Inc. (AVTR) has a median price target of $13.00. The highest price target is $19.00 and the lowest is $12.00.

Is AVTR stock a good investment in 2026?

According to current analyst ratings, AVTR has 5 Buy ratings, 13 Hold ratings, and 0 Sell ratings. The stock is currently trading at $11.38. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for AVTR stock?

Wall Street analysts predict AVTR stock could reach $13.00 in the next 12 months. This represents a 14.2% increase from the current price of $11.38. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Avantor Inc.'s business model?

Avantor Inc. generates revenue by supplying a comprehensive range of laboratory chemicals, consumables, equipment, and instrumentation to various sectors, including life sciences, advanced technologies, and applied materials. The company serves a diverse clientele, including pharmaceutical, biotechnology, academic, and government institutions, facilitating their research, development, and manufacturing processes.

What is the highest forecasted price for AVTR Avantor Inc.?

Price targets from Wall Street analysts for AVTR are not currently available. The stock is trading at $11.38.

What is the lowest forecasted price for AVTR Avantor Inc.?

The lowest price target for AVTR is $12.00 from Luke Sergott at Barclays, which represents a 5.4% increase from the current price of $11.38.

What is the overall AVTR consensus from analysts for Avantor Inc.?

The overall analyst consensus for AVTR is neutral. Out of 32 Wall Street analysts, 5 rate it as Buy, 13 as Hold, and 0 as Sell, with a median price target of $13.00.

How accurate are AVTR stock price projections?

Stock price projections, including those for Avantor Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: November 16, 2025 1:51 AM UTC
Serious About Growing Your Portfolio?

We highlight 2 high-upside stocks each month – no fluff.

Missedย NVDA?
Donโ€™t Miss the Next One.

Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ€” for free.